Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'.

Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'. Eur J Endocrinol. 2020 Dec;183(6):L29-L30 Authors: Michelet R, Melin J, Parra-Guillen ZP, Neumann U, Whitaker MJ, Stachanow V, Huisinga W, Porter J, Blankenstein O, Ross RJ, Kloft C PMID: 33105103 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33105103?dopt=Abstract

Source: European Journal of Endocrinology - October 28, 2020 Category: Endocrinology Authors: Michelet R, Melin J, Parra-Guillen ZP, Neumann U, Whitaker MJ, Stachanow V, Huisinga W, Porter J, Blankenstein O, Ross RJ, Kloft C Tags: Eur J Endocrinol Source Type: research

More News: Children | Congenital Adrenal Hyperplasia | Endocrinology | Hydrocortisone